A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
Autor Principal: | Shehab, Habibul Mohsin |
---|---|
Outros autores: | Yasmin, Hasina |
Formato: | Thesis |
Idioma: | English |
Publicado: |
Brac University
2024
|
Subjects: | |
Acceso en liña: | http://hdl.handle.net/10361/22683 |
Títulos similares
-
Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
por: Tabassum, Nadira
Publicado: (2024) -
Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
por: Mahee, Sadique Abdal
Publicado: (2024) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
por: Alim, Abdul
Publicado: (2023) -
Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
por: Karmaker, Swastika
Publicado: (2024) -
A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
por: Jahan, Nusrat
Publicado: (2023)